Jeff Jonker has been named president of NGM Biopharmaceuticals, Inc., and David Woodhouse, Ph.D., has been appointed chief financial officer, effective immediately.   Prior to joining the company, Mr. Jonker was senior vice president, corporate and business development at Theravance Biopharma and Theravance, Inc. He previously served as chief business officer of Satori Pharmaceuticals and vice president of business development and corporate strategy for Gloucester Pharmaceuticals, prior to its a...